Literature DB >> 18972285

Nonadherence to medical therapy in asthma: risk factors, barriers, and strategies for improving.

Gregory Howell1.   

Abstract

Asthma is a very prevalent disease in the United States, and the incidence is rising for a variety of reasons. Although progress has been made on several therapeutic fronts, adherence to asthma therapy, particularly controller medications, remains poor. This review of data from the past five years will focus on factors associated with nonadherence, barriers to adherence, factors associated with adherence, and finally strategies for improving. Communication between the health care provider and patient is paramount in improving adherence to medical therapy for asthma and thereby improving control of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18972285     DOI: 10.1080/02770900802395512

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  17 in total

1.  The active patient role and asthma outcomes in an underserved rural community.

Authors:  Henry N Young; Tonja L Larson; Elizabeth D Cox; Megan A Moreno; Joshua M Thorpe; Neil J MacKinnon
Journal:  J Rural Health       Date:  2013-06-11       Impact factor: 4.333

2.  Evaluation of factors affecting adherence to asthma controller therapy in chest clinics in a sub-Saharan African setting: a cross-sectional study.

Authors:  Bertrand Hugo Mbatchou Ngahane; Eric Walter Pefura-Yone; Maïmouna Mama; Bruno Tengang; Motto Malea Nganda; Adeline Wandji; Ubald Olinga; Emmanuel Nyankiyé; Emmanuel Afane Ze; Christopher Kuaban
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  Barriers to medication use in rural underserved patients with asthma.

Authors:  Henry N Young; Shada Kanchanasuwan; Elizabeth D Cox; Megan M Moreno; Nadra S Havican
Journal:  Res Social Adm Pharm       Date:  2014-12-23

4.  Child and caregiver involvement and shared decision-making during asthma pediatric visits.

Authors:  Betsy L Sleath; Delesha M Carpenter; Robyn Sayner; Guadalupe X Ayala; Dennis Williams; Stephanie Davis; Gail Tudor; Karin Yeatts
Journal:  J Asthma       Date:  2011-10-25       Impact factor: 2.515

5.  Patient and phaRmacist telephonic encounters (PARTE) in an underserved rural patient population with asthma: results of a pilot study.

Authors:  Henry N Young; S Nadra Havican; Sara Griesbach; Joshua M Thorpe; Betty A Chewning; Christine A Sorkness
Journal:  Telemed J E Health       Date:  2012-06-01       Impact factor: 3.536

6.  Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol.

Authors:  Peter N Huynh; Lyne G Scott; Kenny Yc Kwong
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

7.  Patient And phaRmacist Telephonic Encounters (PARTE) in an underserved rural population with asthma: methods and rationale.

Authors:  Henry N Young; S Nadra Havican; Betty A Chewning; Christine A Sorkness; Xin Ruppel; Sara Griesbach
Journal:  Innov Pharm       Date:  2011-07-01

8.  Asthma education: different viewpoints elicited by qualitative and quantitative methods.

Authors:  Scott A Damon; Richard R Tardif
Journal:  J Asthma       Date:  2014-10-01       Impact factor: 2.515

9.  Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study.

Authors:  Anna Bodzenta-Lukaszyk; Andrzej Dymek; Kirsten McAulay; Heikki Mansikka
Journal:  BMC Pulm Med       Date:  2011-05-23       Impact factor: 3.317

10.  Barriers to asthma treatment in the United States: results from the global asthma physician and patient survey.

Authors:  Michael S Blaiss; Michael A Kaliner; Carlos E Baena-Cagnani; Ronald Dahl; Erkka J Valovirta; Giorgio W Canonica
Journal:  World Allergy Organ J       Date:  2009-12       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.